Skip to main content
. Author manuscript; available in PMC: 2018 Feb 21.
Published in final edited form as: AIDS Behav. 2018 Feb;22(2):402–411. doi: 10.1007/s10461-017-1811-9

Table 3.

Adherence and use experiences

PK results (active arm only) Cohort 1
37–39 weeks gestation (N = 29)
Cohort 2
34–36 weeks gestation (N= 31)
Total (N = 60)
Drug detectable 17 (59%) 16 (52%) 33 (55%)
Drug not detectable 12 (41%) 15 (48%) 27 (45%)

Behavioral questionnaires Cohort 1
37– 39 weeks gestation (N = 44)a
Cohort 2
34 – 36 weeks gestation (N = 46)
Total (N = 90)a

Number of days inserted gel at homeb
 Never 1 (2%) 1 (1%)
 1–4 4 (9%) 6 (13%) 10 (11%)
 5 or morea 40 (91%) 39 (85%) 79 (88%)
Most important reason for not inserting study gel at homec
 Not applicable, I used the gel every day 35 (80%) 32 (71%) 67 (75%)
 Inserted at clinic 5 (11%) 5 (11%) 10 (11%)
 I forgot 3 (7%) 3 (7%) 6 (7%)
 I physically could not insert it 1 (2%) 1 (1%)
 I didn’t like the feeling of the gel
 I did not have the gel with me 1 (2%) 1 (2%) 2 (2%)
 My sexual partner did not want me to use it
 I was scared it could be bad for me or my baby
 Otherd 3 (%) 3 (%)
Used less than full amount at homec
 Ever 3 (7%) 1 (2%) 4 (4%)
 Never 41 (93%) 44 (98%) 85 (96%)
Self-perceived ability to use gel as instructed at homec
 Very poor
 Poor 1 (2%) 1 (1%)
 Fair 2 (4%) 2 (2%)
 Good 6 (14%) 6 (13%) 12 (13%)
 Very good 8 (18%) 13 (29%) 21 (24%)
 Excellent 30 (68%) 23 (51%) 53 (60%)
Inserted the gel at approximately the same time every day
 Yes 38 (86%) 40 (87%) 78 (87%)
 No 6 (14%) 6 (13%) 12 (13%)

Median (mean, range)

How easy/difficult to insert the gel at the same time every day (from: 1 difficult, to 10, easy) 9 (8.4, 1–10)
a

One evaluable participant did not complete the CASI follow-up questionnaire

b

Includes 10 participants who inserted gel at clinic during the home-dosing period

c

Among 89 participants who used gel at home

d

1 participant described timing too close to previous dose, 1 was told by PI not to dose, 1 response unclear